Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment

PsycEXTRA Dataset ◽

10.1037/e656032010-001 ◽

2005 ◽

Keyword(s):

Cognitive Impairment ◽

Phase Ii ◽

Phase Ii Study ◽

Hiv Positive ◽

Download Full-text

P1-062: A PHASE II STUDY EVALUATING EFFICACY, SAFETY, AND TOLERABILITY OF ORAL BI 425809 IN PATIENTS WITH COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE DEMENTIA

Alzheimer s & Dementia ◽

10.1016/j.jalz.2019.06.087 ◽

2019 ◽

Vol 15 ◽

pp. P256-P256

Author(s):

Glen Wunderlich ◽

Frank Jessen ◽

Miguel Garcia ◽

Zuzana Blahova

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Phase Ii ◽

Phase Ii Study ◽

Alzheimer’S Disease Dementia

Download Full-text

Incorporation of rituximab and liposomal doxorubicin into CODOX-m/IVAC for HIV-negative and HIV-positive adult patients (pts) with untreated Burkitt's lymphoma (BL): Preliminary results of a multicenter phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.8033 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 8033-8033 ◽

Author(s):

S. A. Gregory ◽

P. M. Barr ◽

C. Nabhan ◽

A. Nukala ◽

L. Gallot ◽

...

Keyword(s):

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Burkitt’S Lymphoma ◽

Adult Patients ◽

Burkitt's Lymphoma ◽

Hiv Positive ◽

Preliminary Results ◽

Multicenter Phase ◽

Download Full-text

Phase II study of anti-CD4 idiotype vaccination in HIV positive volunteers

Vaccine ◽

10.1016/s0264-410x(98)00483-6 ◽

1999 ◽

Vol 17 (15-16) ◽

pp. 1837-1845 ◽

Author(s):

I Schedel

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Download Full-text

O4-11-05: A PROOF OF CONCEPT PHASE II STUDY REPURPOSING ATOMOXETINE FOR NEUROPROTECTION IN MILD COGNITIVE IMPAIRMENT: EVIDENCE FOR TARGET ENGAGEMENT, REGULATION OF CSF BIOMARKERS, AND DISEASE-MODIFYING POTENTIAL

Alzheimer s & Dementia ◽

10.1016/j.jalz.2019.06.4804 ◽

2019 ◽

Vol 15 ◽

pp. P1263-P1264

Author(s):

Allan I. Levey ◽

James J. Lah ◽

William T. Hu ◽

Thomas S. Wingo ◽

Chadwick M. Hales ◽

...

Keyword(s):

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Phase Ii ◽

Phase Ii Study ◽

Csf Biomarkers ◽

Proof Of Concept ◽

Target Engagement ◽

Disease Modifying

Download Full-text

21. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study

Schizophrenia Bulletin ◽

10.1093/schbul/sbx021.040 ◽

2017 ◽

Vol 43 (suppl_1) ◽

pp. S15-S15

Author(s):

Michael Sand ◽

David Brown ◽

Kazuyuki Nakagome ◽

Joachim Cordes ◽

Ronald Brenner ◽

...

Keyword(s):

Cognitive Impairment ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug Users

American Journal on Addictions ◽

10.3109/10550499208993153 ◽

1992 ◽

Vol 1 (4) ◽

pp. 332-338

Author(s):

Marc I. Rosen ◽

T. Peter Bridge ◽

Stephanie S. O'Malley ◽

H. Rowland Pearsall ◽

Brenda Martini ◽

...

Keyword(s):

Cognitive Impairment ◽

Intravenous Drug ◽

Hiv Positive ◽

Intravenous Drug Users ◽

Download Full-text

Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug Users

American Journal on Addictions ◽

10.1111/j.1521-0391.1992.tb00359.x ◽

1992 ◽

Vol 1 (4) ◽

pp. 332-338 ◽

Author(s):

Marc I. Rosen ◽

T. Peter Bridge ◽

Stephanie S. O'Malley ◽

H. Rowland Pearsall ◽

Brenda Martini ◽

...

Keyword(s):

Cognitive Impairment ◽

Intravenous Drug ◽

Hiv Positive ◽

Intravenous Drug Users ◽

Download Full-text

P1-084: PET imaging of β-amyloid with florpiramine F18 (18F-AV-45): Preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease

Alzheimer s & Dementia ◽

10.1016/j.jalz.2009.04.088 ◽

2009 ◽

Vol 5 (4S_Part_7) ◽

pp. P197-P197 ◽

Author(s):

Reisa Sperling ◽

Keith Johnson ◽

Michael J. Pontecorvo ◽

Beth Safirstein ◽

Mildred Farmer ◽

...

Keyword(s):

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Clinical Diagnosis ◽

Phase Ii ◽

Pet Imaging ◽

Phase Ii Study ◽

Elderly Subjects ◽

Cognitively Normal ◽

Preliminary Results ◽

Download Full-text

A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy

Schizophrenia Research ◽

10.1016/j.schres.2015.01.041 ◽

2015 ◽

Vol 164 (1-3) ◽

pp. 136-142 ◽

Author(s):

L. Fredrik Jarskog ◽

Martin T. Lowy ◽

Richard A. Grove ◽

Richard S.E. Keefe ◽

Joseph P. Horrigan ◽

...

Keyword(s):

Cognitive Impairment ◽

Receptor Antagonist ◽

Phase Ii ◽

Phase Ii Study ◽

Antipsychotic Therapy ◽

Histamine H3 Receptor ◽

H3 Receptor ◽

Download Full-text

Phase II study of safety, efficacy and pharmacokinetics of BXT-51072 in patients with mild-moderately active ulcerative colitis

Gastroenterology ◽

10.1016/s0016-5085(01)81390-1 ◽

2001 ◽

Vol 120 (5) ◽

pp. A280-A280

Author(s):

S HANAUER ◽

P MINER ◽

A KESHAVARZIAN ◽

E MORRIS ◽

B SALZBERG ◽

...

Keyword(s):

Ulcerative Colitis ◽

Phase Ii ◽

Phase Ii Study ◽

Active Ulcerative Colitis

Download Full-text